Sonoco Products (DA) downgraded at DA Davidson to Neutral, DA Davidson said. $33 price target. Estimates also cut, given the company's new guidance.
Webster Financial (WBS) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $24 price target. Company is leveraged to higher expected mortgage prepay rates.
Western Gas Partners (WES) downgraded at UBS to Neutral from Buy, UBS said. $51 price target. Valuation call.
STOCK COMMENTS / EPS CHANGESAllegiant Travel (ALGT) estimates raised at UBS through 2013, UBS said. Solid guidance for Q3. Buy rating and $75 price target.
Cabela's (CAB) estimates, target boosted at Credit Suisse. Shares of CAB now seen reaching $62, according to Credit Suisse. Estimates also upped, given higher expected comp sales. Outperform rating.Community Health Systems (CYH) target raised at Jefferies to $29, Jefferies said. Easy 2H12 comps and discounted valuation could ignite upward momentum. Hold rating. Medtronic (MDT) target raised at Oppenheimer to $48, Oppenheimer said. Recent peer-group multiple expansion. Outperform rating. Northern Trust (NTRS) numbers lowered at Jefferies. Shares of NTRS now seen reaching $48, Jefferies said. Estimates also lowered on efficiency initiatives. Hold rating. Ocwen Financial (OCN) numbers raised at KBW. Shares of OCN now seen reaching $40, according to Keefe, Bruyette & Woods said. Homeward acquisition should add to earnings. Outperform rating. Onyx Pharmaceuticals (ONXX) numbers increased at BofA/Merrill. ONXX estimates were raised through 2013, Bank of America/Merrill Lynch said. Expect higher Kyprolis sales. Buy rating and new $101 price target. Constellation Brands (STZ - Get Report) numbers raised at UBS. Shares of STZ now seen reaching $42. Estimates also increased as strong depletion trends support positive outlook. Buy rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts